Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study.
Akihiko AsahinaYukari OkuboAkimichi MoritaYayoi TadaAtsuyuki IgarashiRichard G LangleyDelphine DeherderMizuho MatanoVeerle VanvoordenMaggie WangMamitaro OhtsukiHidemi NakagawaPublished in: Dermatology and therapy (2023)
NCT03370133.